Saba Capital Management, L.P. - 31 Mar 2025 SCHEDULE 13D/A Report for abrdn Life Sciences Investors Common Shares, $0.01 par value (HQL)

Filing Manager
Saba Capital Management, L.P.
Reporting Manager
Saba Capital Management, L.P.
Security
abrdn Life Sciences Investors Common Shares, $0.01 par value
Symbol
HQL
Shares outstanding
28.1M shares
Disclosed Ownership
3.19M shares
Ownership
11.4%
Form type
SCHEDULE 13D/A
Filing time
01 Apr 2025, 21:49:04 UTC
Date of event
31 Mar 2025
Next filing
03 Sep 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Saba Capital Management, L.P. 11.36% 3.19M 0 3.19M /s/ Michael D'Angelo General Counsel 0001510281
Boaz R. Weinstein 11.36% 3.19M 0 3.19M /s/ Michael D'Angelo Authorized Signatory 0001608233
Saba Capital Management GP, LLC 11.36% 3.19M 0 3.19M /s/ Michael D'Angelo Attorney-in-fact*